Tariffs and Temptation: Trump's Latest Gamble with Pharmaceuticals President Donald Trump's announcement of a 100% tariff on imported generic pharmaceutical drugs has sent shockwaves through the healthcare industry.
The move is sparking concerns about affordability, access, and the long term implications for patients in the United States.
The administration's stated goal is to "reshore" domestic production and exert control over a massive market that currently relies heavily on imports.